1. Boros AM, Perge P, Merkely B, Széplaki G (2023). Risk scores in cardiac resynchronization therapy- A review of the literature. Front Cardiovasc Med. 2023 Jan 17:9:1048673. Impact factor: 3.6

2. Garbaisz D, Osztrogonácz P, Boros AM, Hidi L, Sótonyi P, Szeberin Z (2022). Comparison of arterial and venous allograft bypass in chronic limb-threatening ischemia. PLoS One. 2022 Oct 27;17(10):e0275628. Impact factor: 3.7 

3. Hidi L, Pomozi E, Boros AM, Legeza P, Bárczi Z, Szeberin Z (2022). [Long-term results of open surgical repair of non-infrarenal abdominal aortic aneurysms]. Orv Hetil. 2022 Sep 11;163(37):1472-1480. Impact factor: 0.6 [Article in Hungarian] 

4. Merkel ED, Boros AM, Schwertner WM, Behon A, Kovács A, Lakatos BK, Gellér L, Kosztin A, Merkely B (2022). Effect of single ventricular premature contractions on response to cardiac resynchronization therapy. BMC Cardiovasc Disord. 2022 Jun 25;22(1):289. Impact factor: 2.1

5. Hidi L, Pál D, Boros AM, Kováts T, Menyhei G, Szeberin Z (2022). [Analysis of data from the National Vascular Registry on infrarenal aortic aneurysms (2010–2019)]. Orv Hetil. 2021 Aug 1;162(31):1233-1243. Impact factor: 0.707 [Article in Hungarian] 

6. Lakatos BK, Nabeshima Y, Tokodi M, Nagata Y, Tősér Z, Otani K, Kitano T, Fábián A, Ujvári A, Boros AM, Merkely B, Kovács A, Takeuchi M (2020). Importance of Nonlongitudinal Motion Components in Right Ventricular Function: Three-Dimensional Echocardiographic Study in Healthy Volunteers. J Am Soc Echocardiogr. 2020 Aug;33(8):995-1005.e1. Impact factor: 5.251 

7. Tokodi M, Schwertner WR, Kovács A, Tősér Z, Staub L, Sárkány A, Lakatos BK, Behon A, Boros AM, Perge P, Kutyifa V, Széplaki G, Gellér L, Merkely B, Kosztin A (2020). Machine learning-based mortality prediction of patients undergoing cardiac resynchronization therapy: the SEMMELWEIS-CRT score. Eur Heart J. 2020 May 7;41(18):1747-1756.  Impact factor: 29.983 

8.  Perge P, Boros AM, Gellér L, Osztheimer I, Szilágyi S, Tahin T, Apor A, Nagy KV, Zima E, Molnár L, Merkely B, Széplaki G (2019). Vitamin D Deficiency Predicts Poor Clinical Outcomes in Heart Failure Patients Undergoing Cardiac Resynchronization Therapy. Dis Markers. 2019 Oct 13:2019:4145821. Impact factor: 2.738 

9. Kosztin A, Boros AM, Merkel E, Schwertner WR, Behon A, Merkely B. (2019). Improved life expectancy in patients after dual-chamber pacemaker implantation. Kardiol Pol. 2019 Aug 23;77(7-8):659-660. Impact factor: 1.874 

10. Tahin T, Herczeg S, Geller L, Boros AM, Kovács OM, Szegedi N, Fórizs É, Szilágyi S, Osztheimer I, Merkely B, Széplaki G. (2019). [Assessment of the extent of myocardial necrosis following radiofrequency catheter ablation of different supraventricular arrhythmias]. Orv Hetil. 2019 Apr;160(14):540-548. Impact factor: 0.497 [Article in Hungarian] 

11. Perge P, Boros AM, Szilagyi S, Zima E, Molnar L, Geller L, Prohaszka Z, Mekely B, Szeplaki G. (2019). Novel Biomarkers in Cardiac Resynchronization Therapy: Hepatocyte Growth Factor is an Independent Predictor of Clinical Outcome. Rev Esp Cardiol (Engl Ed). 2019 Jan;72 (1):48-55. Impact factor: 4.642 

12. Perge P, Boros AM, Szilagyi S, Zima E, Molnar L, Geller L, Merkely B, Széplaki G. (2018) Hyperuricemia predicts adverse clinical outcomes after cardiac resynchronization therapy. Scand Cardiovas J. 2018 Oct;52(5):250-255. Impact factor: 1.286 

13. Nagy VK, Szeplaki G, Boros AM, Perge P, Molnar L, Szilagyi S, Tahin T, Zima E, Kutyifa V, Gellér L, Merkely B. (2018). Quality of life measured with EuroQol-5D questionnaire predicts long term mortality, response and reverse remodelling in CRT patients. Europace. 2018 Sep 1;20 (9):1506-1512. Impact factor: 6.1 

14. Garbaisz D, Boros AM, Legeza P, Szeberin Z (2018). [Open and endovascular repair of iliac artery aneurysms]. Orv Hetil.  2018 Apr;159(13):520-525. Impact factor: 0.564 [Article in Hungarian] 

15. Kosztin A, Boros AM, Geller L, Merkely B (2018). Application of "AL-FINE CRT" risk score before cardiac resynchronisation therapy implantation. Kardiol Pol. 2018;76(10):1418-1419. Impact factor: 1.674 

16. Kosztin A, Boros AM, Geller L, Merkely B (2018). Cardiac resynchronization therapy: current benefits and pitfalls. Kardiol Pol. 2018;76(10):1420-1425. Impact factor: 1.674 

17. Merkely B, Kosztin A, Roka A, Geller L, Zima E, Kovacs A, Boros AM, Klein H, Wranicz JK, Hindricks G, Clemens M, Duray GZ, Moss AJ, Goldenberg I, Kutyifa V (2017). Rationale and design of the BUDAPEST-CRT Upgrade Study: a prospective, randomized, multicentre clinical trial. Europace. 2017 Sep 1;19(9):1549-1555. Impact factor: 5.231 

18. Boros AM, Perge P*, Nagy KV, Apor A, Bagyura Z, Zima E, Molnár L, Tahin T, Becker D, Gellér L, Merkely B, Széplaki G (2017). The impact of cardiac resynchronization therapy on routine laboratory parameters. Interv Med Appl Sci. 2017 Mar;9(1):1-8. Impact factor: 0 

19. Széplaki G, Boros AM, Szilágyi S, Osztheimer I, Jenei Z, Kosztin A, Nagy KV, Karády J, Molnár L, Tahin T, Zima E, Gellér L, Prohászka Z, Merkely B (2016). Complement C3a predicts outcome in cardiac resynchronization therapy of heart failure. Inflamm Res. 2016 Dec;65(12):933-940. Impact factor: 2.659 

20. Boros AM, Széplaki G*, Perge P, Jenei Z, Bagyura Z, Zima E, Molnár L, Apor A, Becker D, Gellér L, Prohászka Z, Merkely B (2016). The ratio of the neutrophil leucocytes to the lymphocytes predicts the outcome after cardiac resynchronization therapy. Europace. 2016 May;18(5):747-54. Impact factor: 4.530 

21. Boros AM, Perge P, Jenei Z, Karády J, Zima E, Molnár L, Becker D, Gellér L, Prohászka Z, Merkely B, Széplaki G (2016). Measurement of the Red Blood Cell Distribution Width Improves the Risk Prediction in Cardiac Resynchronization Therapy. Dis Markers. 2016:2016:7304538. Impact factor: 2.348 

22. Nagy VK, Széplaki G, Apor A, Kutyifa V, Kovács A, Kosztin A, Becker D, Boros AM, Gellér L, Merkely B (2015) Role of Right Ventricular Global Longitudinal Strain in Predicting Early and Long-Term Mortality in Cardiac Resynchronization Therapy Patients. PLoS One. 2015 Dec 23;10(12):e0143907. Impact factor: 3.057